Human Longevity Raises $220M

San Diego-based Human Longevity, a genomics technology developer, has raised $220M in a Series B funding, according to the company. The funding came from Illumina, Celgene, GE Ventures, as well as others. Human Longevity--led by genomics pioneer J. Craig Venter, Ph.D.--said the new funding comes on top of an earlier, $80M in a Series A round which closed in Summer of 2014. Human Longevity (HLI) said the proceeds will go towards growth and expansion of the company. HLI says it is creating the world's largest database of whole genome, phenotype and clinical data, and will use large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine using that data. The company states on its website that it is specifically looking to extend the lifespan of humans and tackle aging. More information »